Effect of Cyclosporine A on Hearing in Children with Steroid Resistant Nephrotic Syndrome

Ahmed Tarek Abdel Fattah Soliman;

Abstract


The aim of this study is to assess hearing defects in children with steroid resistant nephrotic syndrome (SRNS), before and after receiving CsA for 6 months.
Twenty five pediatric patients with SRNS in pediatric nephrology clinic, Children's hospital, Ain Shams University, were trialed to evaluate hearing defects before and after receiving CsA for 6 months.
Patients were subjected to history taking including (age, gender, age at first clinical presentation, reports of biopsies, systemic diseases, ear problems, previous ENT operations and ototoxic drug intake). Basic audiological evaluation including (Pure Tone Audiometry, Speech Audiometry and Acoustic Immitancemetrey) were done before and 6 months after initiation of CsA treatment.
Valid cases showed that the average mean hearing threshold shows non-significant changes before and after six months of cyclosporine treatment with (p= 0.954) at 250 Hz, (p= 0.868) at 500 Hz, (p= 0.473) at 1000 Hz, (p= 0.680) at 2000 Hz, (p= 0.535) at 4000 Hz and (p= 0.865) at 8000 Hz respectively.
There was no correlation between age, weight, height, age at first clinical presentation, duration of corticosteroid intake, regarding average of hearing before and after six months of cyclosporine treatment.
Concerning speech and language evaluation, all patients had bilateral excellent speech discrimination before and after CsA treatment


Other data

Title Effect of Cyclosporine A on Hearing in Children with Steroid Resistant Nephrotic Syndrome
Other Titles تأثير السيكلوسبورين أ على السمع لدى الأطفال الذين يعانون من المتلازمة الكلوية المقاومة للكورتيزون.
Authors Ahmed Tarek Abdel Fattah Soliman
Issue Date 2019

Attached Files

File SizeFormat
J2900.pdf711.56 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 10 in Shams Scholar
downloads 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.